INTRODUCTION
Osteoporosis and Vertebral Compression Fractures
Osteoporosis affects 200 million individuals worldwide1 and is an especially common problem among elderly females, resulting in thoracic and lumbar vertebral compression fractures (VCF). It is estimated that 25% of women over age 50 will experience one or more VCF2,3 and there are 700,000 VCF annually4 with an enormous economic impact.5 According to the World Health Organization, osteoporosis is diagnosed when an individual's bone density t-score is 2.5 standard deviations below the mean as measured by a dual emission x-ray absorptiometry (DEXA) scan.6 Osteopenia, the precursor to osteoporosis, is characterized by a t-score of 1 to 2.5 standard deviations below the mean.6
The complications of osteoporosis and VCF include pain, postural deformities with related pulmonary compromise, impaired balance, decreased mobility and function, and more frequent and longer hospital stays.7–9 Additionally, these fractures may trigger a decline in health resulting in permanent disability or death of the older adult.9–11
Compression fractures may result from a fall or minor trauma.12 Sometimes VCF occur spontaneously with simple activities like coughing; turning or twisting; attempting to rise from a chair; stepping on or off a step; or picking up an object, pet, or grandchild.3,12 Vertebral compression fractures involving the anterior portion of the vertebral body are called anterior wedge fractures. These fractures are usually stable and do not result in neurological compromise. Burst fractures involve the entire vertebral body and may be unstable.13 Both types of VCF alter spinal postural alignment and support of the vertebral column.14 Changes in postural alignment may lead to pain, respiratory compromise, and impaired functional mobility.8,9,14 A single VCF may result in a 9% loss of forced vital capacity.15 Pain frequently increases with weight bearing, is most severe during the first few weeks, and decreases with rest and inactivity.12 Individual pain tolerance is variable, resulting in different levels of functional limitation.3
Conservative Intervention for VCF
Conservative, nonoperative intervention following VCF focuses on pain relief, strengthening, limiting motion of the spine, and maintaining functional activities within the individual's ability and tolerance.16,17 Bed rest, immobility, analgesics, and bracing are common nonsurgical interventions for VCF.18,19 Bracing provides support, decreases pain, and allows improved functional mobility.20,21
Surgical Intervention
When conservative intervention does not provide desired results within a few weeks or months, VCF can be treated surgically.4 Surgical intervention, known as percutaneous vertebral augmentation (PVA), following VCF includes surgical techniques called vertebroplasty and kyphoplasty .16,22 Other PVA terminology includes percutaneous vertebroplasty and balloon kyphoplasty .23 These procedures are being used with increased frequency in the United States.
Vertebroplasty was developed in France in 1984.24 Although vertebroplasty was initially used to treat patients with cancer, it has gained popularity for other conditions and patient populations.23,24 Vertebroplasty is performed while a patient is prone and under local or general anesthesia. It involves fluoroscopic imaging to guide the injection of polymethylmethacrylate cement into the fractured vertebral body to hold and support the fractured bone.23,24
Kyphoplasty was first used in the United States in 1988.22 During kyphoplasty , the surgeon creates a space by expanding a ‘balloon’ in the vertebral body and then fills the space with bone cement.22,25 After the cement is inserted, the patient is placed in supine for approximately 1 hour while the cement hardens.24 Further procedural details related to PVA are described by Deen et al,11 Mathis et al,23 and Deramond et al.24
Both vertebroplasty and kyphoplasty provide pain relief and support the vertebral column. In addition, kyphoplasty restores vertebral height21,25–27 and has a decreased chance of cement leakage compared to vertebroplasty .22 However, Mathis et al report that kyphoplasty minimally improves vertebral height, involves greater risk due to the use of general anesthesia, and costs 10 to 20 times more than vertebroplasty .26 Neither vertebroplasty nor kyphoplasty has been compared to conservative treatment in a randomized trial.26
Purpose
The purpose of this systematic literature review was to provide the reader with information on the efficacy of PVA following VCF as well as the use of physical therapy intervention after PVA. It is hoped that this information will heighten awareness of the increasing use of surgical intervention for VCF and encourage physical therapists to identify the most appropriate interventions for the rehabilitation of individuals status post PVA.
METHODS
A search was conducted using Medline and the Cumulative Index of Nursing and Allied Health Literature (CINAHL) for the years between January 1990 and August 2005. Key words for the search included: vertebroplasty , kyphoplasty , physical therapy , rehabilitation , and outcomes . Additional searches were completed using the Physiotherapy Evidence Database (PEDro) and the Cochrane Database of Systematic Reviews (Cochrane Reviews), as well as the Agency for Healthcare Research and Quality (AHRQ): National Guideline Clearinghouse using key words vertebroplasty , kyphoplasty , and compression fracture.
Studies were initially reviewed by title and abstract. Inclusion criteria (Table 1 ) included whether the study was quantitative, available in English, and included physical therapy , rehabilitation , or functional outcomes compared over time following PVA secondary to osteoporotic VCF of the lumbar or thoracic spine in older adults.
Table 1: Quality Scoring Criteria and Percentage of Studies Satisfying the Criteria
Quality Scoring
A quality scoring system was developed to allow comparison of the articles. The quality scoring system was modeled after a study by Cleland and Durall28 and consisted of data present (point given) or not present (point not given). The greater the number of scoring criteria present, the higher the number of points received by that article. The quality score (percentage) was calculated by dividing each article's points by the 20 points possible. Table 1 lists the criteria of the quality scoring system, and the percentage of articles satisfying each criterion. Table 2 provides the quality score assigned to each article.
Table 2: Studies Included in this Systematic Review
RESULTS
No studies were found with searches on PEDro, Cochrane Reviews, or the AHRQ: National Guideline Clearinghouse. Searches in CINAHL and Medline resulted in 67 articles (21 and 53 respectively, with 7 duplicates) examining outcomes , rehabilitation , or physical therapy following PVA. After reviewing the title, description, abstract, or full text of the 67 articles, 36 were excluded because they were not research studies or lacked functional outcome measures. Seven studies were excluded because they focused on conditions other than VCF, and 6 were excluded because their focus was on surgical technique or specific surgical procedures. Three articles were excluded because they were case studies or literature reviews. One article was excluded because of the inconsistent use of assessments for subjects and another was excluded because only the abstract was available. Four additional articles, located through reference review, met the inclusion criteria and were used, bringing the total to 17 studies.
Of the 17 studies (Table 2 ), there were 10 prospective nonrandomized studies without a control group, 5 retrospective studies, and 2 prospective nonrandomized controlled trials. None of the studies was a randomized controlled trial. Table 3 provides data related to questions and variables, study design, sample size and profile, complications, and conclusions of each study.
Table 3: Summary of Studies Reviewed (the articles are grouped according to study design and are listed in reverse chronological order)
Table 3: Continued.
Nonrandomized Controlled Trials
The prospective nonrandomized controlled trials by Kasperk et al29 and Diamond et al30 had a mean quality score of 73% (Table 4 ). Both studies included a control group and had greater than 30 subjects. Both studies employed multiple outcome assessments that focused on pain, function, and use of pain medication. Both studies described complications following PVA and 1 study reported fracture status and discharge information. Neither study measured psychological outcomes . Conservative treatment was attempted in 1 study; however, neither study addressed physical therapy intervention following PVA.
Table 4: Scoring Criteria
Retrospective Studies
The mean quality score for the 5 retrospective studies31–35 was 63% (Table 4 ). All 5 studies had greater than 30 subjects, but lacked a control group. Four did not report psychological considerations, failed to mention discharge information, or did not include patients' fracture status. Three studies did not mention medication use or failed to identify who performed the outcome assessment. Two studies did not report study limitations. Only 3 studies completed multiple outcome assessments and included complications following PVA. Four studies reported use of conservative treatment prior to surgical intervention. None of the studies included physical therapy intervention following PVA.
Prospective Studies
The mean quality score for the 10 prospective nonrandomized studies without controls36–45 was 66% (Table 4 ). All of the prospective studies measured pain, function, and described complications following PVA but lacked a control group. Four studies had less than 30 subjects. Eight studies did not mention who performed the outcome assessments and 7 studies did not report study limitations. Only 7 studies included multiple outcome assessments. Five studies did not mention medication use or include fracture status, and 2 had no information related to psychological assessments. Seven studies reported discharge information, and 9 studies used conservative treatment prior to surgical intervention; however, none of the studies included physical therapy intervention following PVA.
Outcomes of PVA
Based upon the 17 studies in this systematic literature review, overall outcomes following PVA are favorable. After PVA, patients reported decreased pain29–33,35–45 and medication use,31,35,38,44 increased function,29–33,35,36,39,40,43–45 and improved quality of life.33,34,37–39,41 Decreased hospital stay33 and fewer physician visits29 were also reported. Mean hospital stay was 1.7 days for kyphoplasty with 82% of patients discharged to home, 11% to rehabilitation facilities, and 5% to skilled care centers.33 Diamond et al described a 40% decrease in hospital stay for patients with vertebroplasty compared to those treated conservatively.30 Most of the studies reported decreased pain following PVA29–33,35–45 that was sustained over time.36,40 The amount and type of medication used changed post PVA.31,35,38,44 Medications typically used prior to PVA included narcotics and prescription non-narcotics, while medications used post PVA included fewer prescription non-narcotics and over-the-counter medications such as aspirin, acetaminophen, and nonsteroidal anti-inflammatory drugs.38 Evans et al reported a substantial decrease in scheduled oral narcotics and other medications following PVA.31 Diamond et al found that 25% of patients stopped all pain medications within 24 hours following vertebroplasty compared to no decease in pain medication for the control group.30
Kyphoplasty was reported to restore vertebral body height (VBH) by as much as 12% compared to an 8% decrease in VBH for individuals treated conservatively.29 Lieberman et al reported that VBH was restored by an average of 35% following PVA.43 Significant changes in VBH were also noted when measured radiographically, showing an average anterior VBH increase of 4.6 mm.34 Even 1 year post PVA, anterior VBH remained at 85% of predicted levels, while midline VBH remained at 89% of predicted levels.33
Ambulation, physical function, and quality of life improved following PVA.29–41,43–45 Evans et al reported that 18% of patients were bedridden and 55% were in wheelchairs or had limitations in ambulation prior to PVA.31 Following PVA, 70% of patients had normal ambulation, and 63% were able to perform activities of daily living with little or no pain.31 Improved physical function44 and quality of life41 were sustained 6 months post PVA. Diamond et al reported a 29% increase in physical function following vertebroplasty compared to no improvement in the control group.30
Fourteen studies reported complications following PVA.29–31,33,34,36,37,39,40–45 Two studies did not address complications32,35 and Do et al reported that no complications occurred as a result of PVA.38 Cement leakage was the most common complication following PVA.29,31,34,36,37,39–44 Results of cement leakage varied from no symptoms,34,36,37,39,41,43 to radiculopathy,31,40,44 and lower limb paresis.29 Chen et al reported the need for surgical decompression due to cement leakage.42 Additional fractures were noted in 4 studies30,31,34,41 including vertebral compression fractures, and fractures of transverse processes and ribs. Other medical complications, not directly related to PVA, included myocardial infarction,39,43,45 pulmonary embolism,33,36 and exacerbation of medical conditions such as congestive heart failure and pulmonary edema.43,45
While the 17 studies demonstrated the effectiveness of PVA, there was little consistency in discharge criteria following the procedure. In some studies, patients were discharged based upon a specific time frame.29,36,37,39,42,44 Two studies based discharge upon patient status.31,38 Evans et al reported immobilization for 1 hour following PVA with discharge once patients could ambulate31 and Do et al discharged patients when medically stable.38 McGraw et al used positioning and time as a reference for progressing the patient prior to discharge.40 They observed the patient in supine for 1 hour, in sitting for 1 hour, and then allowed the patient to stand; however, did not specify a time frame for discharge.40 Chen et al discharged patients with a thoracolumbar support within 24 hours following PVA.42 Other authors described discharge based upon time including 3 hours,36 overnight observation,44,45 or 48 hours29 as the guide. One study kept patients supine for 24 hours and discharged them 3 days after PVA.37
None of the 17 studies mentioned physical therapy intervention following PVA; however, patients may have received physical therapy intervention prior to discharge. Nine studies described discharge information; although there was no consistency between studies, nor was there a reference to physical therapy intervention that may have affected the outcomes of PVA.29,31,36–40,42,44 One study required that patients attain a predetermined functional level prior to discharge but did not indicate that physical therapy intervention was provided.31
DISCUSSION
The purpose of this systematic literature review was to present a summary of research findings regarding the efficacy of PVA and the incorporation of physical therapy intervention following PVA. All of the studies in this systematic review supported the use of kyphoplasty or vertebroplasty ; however, none recommended PVA be used in place of conservative treatment. None of the studies evaluated discussed the incorporation of physical therapy intervention following PVA.
Efficacy of PVA
Conservative treatment for VCF may be effective; however, when bed rest, bracing, and analgesics do not provide pain relief, there is growing evidence to support PVA. Fourteen studies attempted conservative treatment but when conservative treatment failed to provide symptom relief, PVA was performed.29,31–34,36–38,40–45 Patients with limited progress following conservative treatment may find pain relief following PVA, thus improving functional mobility and quality of life. Two studies, excluded from this review because they did not examine functional outcomes , reported that PVA decreased pain and was a safe and effective procedure.46,47 These results are consistent with the studies included in this review. Lower levels of pain may lead to decreased medication use, encouraging earlier return to function and preventing further debilitation and secondary complications of immobility.9,10,12
Although the evaluated studies supported the use of PVA, some concerns were noted when PVA was used during the acute stage following VCF. Treating acute fractures with PVA increased the risk for cement leakage; therefore, it was recommended that surgical intervention be withheld until the subacute stage.48,49 However, the time necessary for conservative treatment may lead to secondary complications from bed rest and immobility.18,19,24 Prolonged pain, immobility, and limited function present during conservative treatment can lead to molecular changes in bone and cardiorespiratory compromise.9,50 When PVA is finally performed, the patient's status may have already deteriorated.
The complications following PVA described in this systematic review were similar to complications reported in studies that did not meet our inclusion criteria. The most commonly reported complication following vertebroplasty and kyphoplasty was cement leakage.51 Deramond et al reported increased incidence of cement leakage that was related to destruction of the vertebral body.24 According to Gafin et al, there is more risk of leakage with vertebroplasty than kyphoplasty .51 Bone cement leakage was reported in 30% to 67% of patients following vertebroplasty but less than 1% to 10% leakage with kyphoplasty .51,52 Few patients were found to be symptomatic with either procedure.46,51
Additional complications, identified in the literature describing surgical techniques, were not reported in the 17 studies evaluated in this systematic review. In addition to complications of PVA such as increased pain and rib or vertebral fracture, other studies identified hemorrhage, fever, and infection as complications.4,46,47,51 While PVA is reported to be a safe and effective treatment, it is important to note that serious complications, such as pneumothorax, radiculopathy or spinal cord compression, and cement pulmonary embolism, have occurred in 1% to 10% of cases.4,7,24,51,53,54 Uppin et al reported an increased incidence of VCF following PVA, with 22 of 177 patients (12.4%) experiencing additional VCF.55 Two-thirds of these fractures occurred in vertebrae adjacent to cemented vertebrae.55
Physical Therapy Intervention Following PVA
With limited data available regarding discharge criteria and rehabilitation following PVA, evidence-based practice guidelines have not been developed. Physical therapists are specifically qualified to develop guidelines for patients with VCF, whether or not they have undergone PVA. Specific practice patterns supporting intervention after PVA already exist in the Guide to Physical Therapist Practice and include Musculoskeletal Patterns : 4B- Impaired Posture and 4G- Impaired Joint Mobility, Muscle Performance, and Range of Motion Associated with Fracture.56
While physical therapy intervention following PVA was not discussed in the literature, studies were found that provide a framework for program development.4,10,12 In some studies, movement and physical activity were allowed between 2 and 24 hours post PVA.4,10 Larsen reported that dressings could be removed 24 hours after PVA and patients could bathe or shower the following day.12 According to Spivak and Johnson, intervention following PVA should include exercises for spinal extension once pain allows.57 Specific exercises for postural improvement through strengthening trunk extension are reported in the literature.58,59
Implications for Research
Of the 17 studies included in this systematic review, only 2 had a control group.29,30 Both control groups consisted of individuals who declined surgical intervention. Although the control and intervention groups were not matched, both studies described characteristics that were similar between groups. Because of the limited number of studies and the absence of randomized controlled trials related to outcomes following PVA, the results and conclusions of the studies in this systematic review may be limited. Randomized controlled trials should be developed to examine the difference between conservative treatment and PVA. The long-term effects of PVA are not yet known. The longest follow-up study was completed by Perez-Higueras et al who found that pain reduction was still significant 5 years postsurgical intervention.46 Longitudinal studies should be completed to determine the long-term efficacy of PVA.
Studies should compare the outcomes of patients receiving physical therapy intervention following VCF, whether treated conservatively or with PVA, with those receiving no physical therapy intervention. Outcome measures could include measures of spinal posture as well as pain, physical function, medication use, and quality of life. Kyphotic posture negatively affects patients' balance, respiratory status, and risk for falls and future VCF.8,9 Using a reliable device to measure posture would allow comparison of posture before and after PVA, as well as before and after conservative treatment for VCF. Kyphotic curve could be measured using the flexi-curve,60–63 index of kyphosis,61 curviscope,64 Arcometer,65 or mid-sagittal contour gauge.66 Respiratory status could be assessed by measuring vital capacity and forced expiratory volume using a portable spirometer, allowing correlation between PVA, posture, and respiratory function.
Limitations
This systematic review has several limitations. The search was limited to articles in English and only included 5 databases (Cochrane Reviews, AHRQ: National Guideline Clearinghouse, PEDro, Medline, and CINAHL). While a meta-analysis would be the ideal statistical tool to compare studies, it was not used in this systematic review due to differences and variability in outcomes measured. Another limitation was the use of a quality scoring system to rank the studies. Such a system has been used by other authors to compare studies with variable outcomes or interventions.28,67 The quality scoring system used in this review allowed the 17 studies to be scored and compared. In order to improve consistency, the same investigator determined the absence or presence of scoring criteria for all studies. Additionally, all criteria were weighted equally, thus the importance of each criterion was not quantified. For example, even though 2 studies had control groups, with assigned quality scores of 65%30 and 80%,29 other studies36–38 scored 80% without the inclusion of a control group. The use of a weighted quality scoring system may be useful in future reviews.
CONCLUSION
Although PVA appears to be an effective treatment option for individuals with VCF, further research regarding the use and long term outcomes of PVA would be beneficial. Presently physical therapy is not a standard treatment intervention following PVA. Whether outcomes following PVA might be enhanced with the provision of physical therapy intervention warrants investigation.
REFERENCES
1. Lin JT, Lane JM. Osteoporosis: a review.
Clin Orthop. 2004;425:125-134.
2. Wu SS, Lachmann E, Nagler W. Current medical,
rehabilitation , and surgical management of vertebral compression fractures.
J Womens Health. 2003;12:17-26.
3. Lukert BP. Vertebral compression fractures: how to manage pain, avoid disability.
Geriatrics. 1994;49:22-26.
4. Predey TA, Sewall LE, Smith SF. Percutaneous
vertebroplasty : new treatment for vertebral compression fractures.
Am Fam Physician. 2002;66:611-615.
5. Jarvik JG, Kallmes DF, Mirza SK.
Vertebroplasty : learning more, but not enough.
Spine. 2003;28:1487-1489.
6. Osteoporosis Prevention, Diagnosis, and Therapy. NIH Consensus Statement Online 2000 March 27-29;17:1-36. Available at:
http://consensus.nih.gov/2000/2000Osteoporosis111html.htm . Accessed July 24, 2003.
7. Watts NB. Is percutaneous vertebral augmentation (
vertebroplasty ) effective treatment for painful vertebral fractures?
Am J Med. 2003;114:326-328.
8. Lombardi I Jr, Oliveira LM, Mayer AF, Jardim JR, Natour J. Evaluation of pulmonary function and quality of life in women with osteoporosis.
Osteoporos Int. 2005;16:1247-1253.
9. Haczynski J, Jakimiuk AJ. Vertebral fractures: a hidden problem of osteoporosis.
Med Sci Monit. 2001;7:1108-1117.
10. Ensrud KE, Thompson DE, Cauley JA, et al. Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass.
J Am Geriatr Soc. 2000;48:241-249.
11. Deen HG, Fenton DS, Lamer TJ. Minimally invasive procedures for disorders of the lumbar spine.
Mayo Clin Proc. 2003;78:1249-1256.
12. Larsen D. Percutaneous
vertebroplasty .
Nurs Stand. 2004;18:33-37.
13. Old JL. Vertebral compression fractures in the elderly.
Am Fam Physician. 2004;69:111-116.
14. Schlaich C, Minne HW, Bruckner T, et al. Reduced pulmonary function in patients with spinal osteoporotic fractures.
Osteoporos Int. 1998;8:261-267.
15. Lieberman IH. Spine specialists on-call: osteoporotic vertebral compression fractures-restoring spinal stability and quality of life. Available at:
http://www.spineuniverse.com . Accessed January 5, 2005.
16. Truumees E, Hilibrand A, Vaccaro AR. Contemporary concepts review: percutaneous vertebral augmentation.
Spine J. 2004;4:218-229.
17. Kim DH, Silber JS, Albert TJ. Osteoporotic vertebral compression fractures.
Instr Course Lect. 2003;52:541-550.
18. Rao RD, Singrakhia MD. Painful osteoporotic vertebral fracture.
J Bone Joint Surg Am. 2003;85:2010-2022.
19. Tamayo-Orozco J, Arzac-Palumbo P, Peon-Vidales H, Mota-Bolfeta R, Fuentes F. Vertebral fractures associated with osteoporosis: patient management.
Am J Med. 1997;103:44S-50S.
20. Frost HM. Personal experience in managing acute compression fractures, their aftermath, and the bone pain syndrome, in osteoporosis.
Osteoporos Int. 1998;8:13-15.
21. Rapado A. General management of vertebral fractures.
Bone. 1996;18:191S-196S.
22. Mehbod A, Aunoble S, Le Huec JC.
Vertebroplasty for osteoporotic spine fracture: prevention and treatment.
Eur Spine J. 2003;12:S155-S162.
23. Mathis JM, Wong W. Percutaneous
vertebroplasty : technical considerations.
J Vasc Interv Radiol. 2003;14:953-960.
24. Deramond H, Depriester C, Galibert P, Le Gars D. Percutaneous
vertebroplasty with polymethylmethacrylate: techniques, indications, and results.
Radiol Clin North Am. 1998;36:533-546.
25. Papaioannou A, Watts NB, Kendler DL, Yuen CK, Adachi JD, Ferko N. Diagnosis and management of vertebral fractures in elderly adults.
Am J Med. 2002;113:220-228.
26. Mathis JM, Oritz AO, Zoarski GH.
Vertebroplasty versus
kyphoplasty : a comparison and contrast.
AJNR Am J Neuroradiol. 2004;25:840-845.
27. Garfin SR, Reilley MA. Minimally invasive treatment of osteoporotic vertebral body compression fractures.
Spine J. 2002;2:76-80.
28. Cleland J, Durall CJ.
Physical therapy for adhesive capsulitis: systematic review.
Physiotherapy. 2002;88:450-457.
29. Kasperk C, Hillmeier J, Noldge G, et al. Treatment of painful vertebral fractures by
Kyphoplasty in patients with primary osteoporosis: a prospective nonrandomized controlled study.
J Bone Miner Res. 2005;20:604-612.
30. Diamond TH, Champion B, Clark WA. Management of acute osteoporotic vertebral fractures: a nonrandomized trial comparing percutaneous
vertebroplasty with conservative treatment.
Am J Med. 2003;114:257-265.
31. Evans AJ, Jensen ME, Kip KE, et al. Vertebral compression fractures: pain reduction and improvement in functional mobility after percutaneous polymethylmethacrylate
vertebroplasty - retrospective report of 245 cases.
Radiology. 2003;226:366-372.
32. Brown DB, Glaiberman CB, Gilula LA, Shimony JS. Correlation between preprocedural MRI findings and clinical
outcomes in the treatment of chronic symptomatic vertebral compression fractures with percutaneous
vertebroplasty .
AJR Am J Roentgenol. 2005;184:1951-1955.
33. Ledlie JT, Renfro M. Balloon
kyphoplasty : one-year
outcomes in vertebral body height restoration, chronic pain, and activity levels.
J Neurosurg Spine. 2003;98(Suppl):36-42.
34. Rhyne A III, Banit D, Laxer E, Odum S, Nussman D.
Kyphoplasty : report of eighty-two thoracolumbar osteoporotic vertebral fractures.
J Orthop Trauma. 2004;18:294-299.
35. Kaufmann TJ, Jensen ME, Schweickert PA, Kallmes DF. Age of fracture and clinical
outcomes of percutaneous
vertebroplasty .
AJNR Am J Neuroradiol. 2001;22:1860-1863.
36. Zoarski GH, Snow P, Olan WJ, et al. Percutaneous
vertebroplasty for osteoporotic compression fractures: quantitative prospective evaluation of long-term
outcomes .
J Vasc Interv Radiol. 2002;13:139-148.
37. Cortet B, Cotton A, Boutry N, et al. Percutaneous
vertebroplasty in the treatment of osteoporotic vertebral compression fractures: an open prospective study.
J Rheumatol. 1999;26:2222-2228.
38. Do HM, Kim BS, Marcellus ML, Curtis L, Marks MP. Prospective analysis of clinical
outcomes after percutaneous
vertebroplasty for painful osteoporotic vertebral body fractures.
AJNR Am J Neuroradiol. 2005;26:1623-1628.
39. Coumans JV, Reinhardt MK, Lieberman IH.
Kyphoplasty for vertebral compression fractures: 1-year clinical
outcomes from a prospective study.
J Neurosurg Spine. 2003;99:44-50.
40. McGraw JK, Lippert JA, Minkus KD, Rami PM, Davis TM, Budzik RF. Prospective evaluation of pain and relief of 100 patients undergoing percutaneous
vertebroplasty : results and follow-up.
J Vasc Interv Radiol. 2002;13:883-886.
41. McKiernan F, Faciszewski T, Jensen R. Quality of life following
vertebroplasty .
J Bone Joint Surg Am. 2004;86A:2600-2606.
42. Chen LH, Niu CC, Yu SW, Fu TS, Lai PL, Chen WJ. Minimally invasive treatment of osteoporotic vertebral compression fracture.
Chang Gung Med J. 2004;27:261-267.
43. Lieberman IH, Dudeney S, Reinhardt MK, Bell G. Initial outcome and efficacy of “
kyphoplasty ” in the treatment of painful osteoporotic vertebral compression fractures.
Spine. 2001;26:1631-1638.
44. Liliang PC, Su TM, Liang CL, Chen HJ, Tsai YD, Lu K. Percutaneous
vertebroplasty improves pain and physical functioning in elderly osteoporotic vertebral compression fracture patients.
Gerontology. 2005;51:34-39.
45. Phillips FM, Ho E, Campbell-Hupp M, McNally T, Wetzel FT, Gupta P. Early radiographic and clinical results of balloon
kyphoplasty for the treatment of osteoporotic vertebral compression fractures.
Spine. 2003;28:2260-2267.
46. Perez-Higueras A, Alvarez L, Rossi RE, Quinones D, Al-Assir I. Percutaneous
vertebroplasty : long-term clinical and radiological outcome.
Neuroradiology. 2002;44:950-954.
47. Grados F, Depriester C, Cayrolle G, Hardy N, Deramond H, Fardellone P. Long-term observations of vertebral osteoporotic fractures treated by percutaneous
vertebroplasty .
Rheumatology. 2000;39:1410-1414.
48. Yu SW, Lee PC, Ma CH, Chuang TY, Chen YJ.
Vertebroplasty for the treatment of osteoporotic compression spinal fracture: comparison of remedial action at different stages of injury.
J Trauma. 2004;56:629-632.
49. Crandall D, Slaughter D, Hankins PJ, Moore C, Jerman J. Acute versus chronic vertebral compression fractures treated with
kyphoplasty : early results.
Spine J. 2004;4:418-424.
50. Phillips FM, Pfeifer BA, Lieberman IH, Kerr EJ III, Choi IS, Pazianos AG. Minimally invasive treatments of osteoporotic vertebral compression fractures:
vertebroplasty and
kyphoplasty .
Instr Course Lect. 2003;52:559-567.
51. Garfin SR, Yuan HA, Reiley MA. New technologies in spine:
kyphoplasty and
vertebroplasty for the treatment of painful osteoporotic compression fractures.
Spine. 2001;26:1511-1515.
52. Lieberman I, Reinhardt MK.
Vertebroplasty and
kyphoplasty for osteolytic vertebral collapse.
Clin Orthop. 2003;415S: S176-S186.
53. Lane JM, Johnson CE, Khan SN, Girardi FP, Cammisa FP Jr. Minimally invasive options for the treatment of osteoporotic vertebral compression fractures.
Orthop Clin North Am. 2002;33:431-438.
54. National Institute for Clinical Excellence (NICE).
Interventional procedure guidance 12: percutaneous vertebroplasty . London; 2003. Available at:
http://www.nice.org.uk . Accessed April 7, 2005.
55. Uppin AA, Hirsch JA, Centenera LV, Pfiefer BA, Pazianos AG, Choi IS. Occurrence of new vertebral body fracture after percutaneous
vertebroplasty in patients with osteoporosis.
Radiology. 2003;226:119-124.
56.
Guide to Physical Therapist Practice. 2
nd ed. Alexandria, Vs: American
Physical Therapy Association; 2001.
57. Spivak JM, Johnson MG. Percutaneous treatment of vertebral body pathology.
J Am Acad Orthop Surg. 2005;13:6-17.
58. Sanaki M, Mikkelson B. Postmenopausal spinal osteoporosis: flexion versus extension exercises.
Arch Phys Med Rehabil. 1984;68:593-596.
59. Meeks S.
Walk Tall: An Exercise Program for the Prevention and Treatment of Osteoporosis. Gainesville, Fla: Triad Publishing; 1999.
60. Anderson JA, Sweetman BJ. A combined flexi-rule/hydrogoniometer for measurement of lumbar spine and its sagittal movement.
Rheumatol Rehabil. 1975;14:173-179.
61. Cutler WB, Freidman E, Genovese-Stone E. Prevalence of kyphosis in a healthy sample of pre- and postmenopausal women.
Am J Phys Med Rehabil. 1993;72:219-25.
62. Rheault W, Ferris S, Foley JA, Schaffhauser D, Smith R. Intertester reliability of the flexible ruler for the cervical spine.
J Orthop Sports Phys Ther. 1989;10:254-256.
63. Hart DL, Rose SJ. Reliability of a noninvasive method for measuring the lumbar curve.
J Orthop Sports Phys Ther. 1986;8:180-184.
64. Cortet B, Houvenagel E, Puisieux F, Roches E, Garnier P, Delcambre B. Spinal curvatures and quality of life in women with vertebral fractures secondary to osteoporosis.
Spine. 1999;24:1921.
65. D'Osualdo F, Schierano S, Iannis M. Validation of clinical measurement of kyphosis with a simple instrument, the arcometer.
Spine. 1997;22:408-413.
66. Landers M, Barker G, Wallentine S, McWhorter JW, Peel C. A comparison of tidal volume, breathing frequency, and minute ventilation between two sitting postures in healthy adults.
Physiother Theory Pract. 2003;19:109-119.
67. Van der Heijin GJMG, Ven der Windt DAWM, Winter AF. Physiotherapy for patients with soft tissue disorder: a systematic review of randomized clinical trials.
BMJ. 1997;315:25-29.